Market Headline News
Headlines from across the market
Stock Market
BioVaxys in Non-Binding Discussions for Major Immunotherapeutics Technology Acquisition
VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that it is in non-binding discussions to acquire an immunotherapeutics intellectual property portfolio of discovery,...
ETF’s
REIT’s
Exchange News
Regulatory Bodies
Contact Us
For exchange news support:
Regulatory News
Media Relations
Public Relations
Disclosure Services
Regulatory News
Media Relations
Public Relations
Disclosure Services